Providing skilled birth attendants and emergency obstetric care to the poor through partnership with private sector obstetricians in Gujarat, India.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 2789362)

Published in Bull World Health Organ on December 01, 2009

Authors

Amarjit Singh1, Dileep V Mavalankar, Ramesh Bhat, Ajesh Desai, S R Patel, Prabal V Singh, Neelu Singh

Author Affiliations

1: Government of Gujarat, Gandhinagar, India.

Articles citing this

Comparative performance of private and public healthcare systems in low- and middle-income countries: a systematic review. PLoS Med (2012) 2.68

Economic inequalities in maternal health care: prenatal care and skilled birth attendance in India, 1992-2006. PLoS One (2010) 1.72

The state-led large scale public private partnership 'Chiranjeevi Program' to increase access to institutional delivery among poor women in Gujarat, India: How has it done? What can we learn? PLoS One (2014) 1.39

Effect of Chiranjeevi Yojana on institutional deliveries and neonatal and maternal outcomes in Gujarat, India: a difference-in-differences analysis. Bull World Health Organ (2013) 1.30

Availability and distribution of emergency obstetric care services in Karnataka State, South India: access and equity considerations. PLoS One (2013) 1.16

Can vouchers deliver? An evaluation of subsidies for maternal health care in Cambodia. Bull World Health Organ (2014) 0.96

Quality care during labour and birth: a multi-country analysis of health system bottlenecks and potential solutions. BMC Pregnancy Childbirth (2015) 0.95

Considerations of private sector obstetricians on participation in the state led "Chiranjeevi Yojana" scheme to promote institutional delivery in Gujarat, India: a qualitative study. BMC Pregnancy Childbirth (2014) 0.88

Predictors of maternal health services utilization by poor, rural women: a comparative study in Indian States of Gujarat and Tamil Nadu. J Health Popul Nutr (2015) 0.88

Has Chiranjeevi Yojana changed the geographic availability of free comprehensive emergency obstetric care services in Gujarat, India? Glob Health Action (2015) 0.88

High neonatal mortality rates in rural India: what options to explore? ISRN Pediatr (2012) 0.83

Contemporary issues in the management of abnormal placentation during pregnancy in developing nations: An Indian perspective. Int J Crit Illn Inj Sci (2013) 0.82

Statewide program to promote institutional delivery in Gujarat, India: who participates and the degree of financial subsidy provided by the Chiranjeevi Yojana program. J Health Popul Nutr (2016) 0.81

Utilization of the state led public private partnership program "Chiranjeevi Yojana" to promote facility births in Gujarat, India: a cross sectional community based study. BMC Health Serv Res (2016) 0.78

Options for Optimal Coverage of Free C-Section Services for Poor Mothers in Indian State of Gujarat: Location Allocation Analysis Using GIS. PLoS One (2015) 0.78

A retrospective observational study of obstetric care in rural Andhra Pradesh by Dangoria Charitable Trust (1979 to 2009). Indian J Med Res (2013) 0.75

Newborn healthcare in urban India. J Perinatol (2016) 0.75

Cost of hospitalization for childbirth in India: how equitable it is in the post-NRHM era? BMC Res Notes (2017) 0.75

Facilitators and barriers to participation of private sector health facilities in government-led schemes for maternity services in India: a qualitative study. BMJ Open (2017) 0.75

Articles by these authors

Maternal health situation in India: a case study. J Health Popul Nutr (2009) 4.89

Maternal healthcare financing: Gujarat's Chiranjeevi Scheme and its beneficiaries. J Health Popul Nutr (2009) 3.46

Innovations and challenges in reducing maternal mortality in Tamil Nadu, India. J Health Popul Nutr (2009) 3.22

Phytochrome E influences internode elongation and flowering time in Arabidopsis. Plant Cell (1998) 3.17

Indian public-private partnership for skilled birth-attendance. Lancet (2008) 2.65

Phytochrome D acts in the shade-avoidance syndrome in Arabidopsis by controlling elongation growth and flowering time. Plant Physiol (1999) 2.42

Saving mothers and newborns through an innovative partnership with private sector obstetricians: Chiranjeevi scheme of Gujarat, India. Int J Gynaecol Obstet (2009) 2.26

Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89

Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther (2010) 1.88

Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol (2001) 1.88

Study of blood-transfusion services in Maharashtra and Gujarat States, India. J Health Popul Nutr (2009) 1.86

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82

A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med (2000) 1.72

Clinical and radiological evidence to support superficial parotidectomy as the treatment of choice for chronic parotid sialadenitis: a retrospective study. Br J Oral Maxillofac Surg (2001) 1.68

Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea. Thorax (2006) 1.62

Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45

The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Clin Pharmacol Ther (2011) 1.43

Identification of patient safety improvement targets in successful vascular and endovascular procedures: analysis of 251 hours of complex arterial surgery. Eur J Vasc Endovasc Surg (2011) 1.40

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg (1998) 1.37

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. Clin Pharmacol Ther (2010) 1.35

Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism. Clin Pharmacol Ther (2012) 1.31

Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest (1997) 1.27

Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol (1997) 1.25

Inequity in maternal health care service utilization in Gujarat: analyses of district-level health survey data. Glob Health Action (2013) 1.19

An evaluation of two large scale demand side financing programs for maternal health in India: the MATIND study protocol. BMC Public Health (2012) 1.19

Commitment among state health officials & its implications for health sector reform: lessons from Gujarat. Indian J Med Res (2008) 1.07

Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution. J Clin Oncol (1997) 1.04

Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the Candidate Gene Association Resource. Diabetologia (2012) 1.03

Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg (1999) 1.03

Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer (2001) 1.02

Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys (2001) 1.01

A review of health system infection control measures in developing countries: what can be learned to reduce maternal mortality. Global Health (2011) 1.01

An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Blood (1994) 1.01

Reporting and concordance of methodologic criteria between abstracts and articles in diagnostic test studies. J Gen Intern Med (2000) 0.99

Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients: are outcomes worsened? Arch Surg (1999) 0.98

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac Surg (2000) 0.97

Role of Sertoli cells in injury-associated testicular germ cell apoptosis. Proc Soc Exp Biol Med (2000) 0.97

Primary extraskeletal osteosarcoma--experience with chemotherapy. J Natl Cancer Inst (1995) 0.97

Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol (2000) 0.96

Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J (1997) 0.92

A clinical study of vitiligo. Indian J Dermatol Venereol Leprol (2007) 0.90

Potentiation by 3,4-dimethoxyphenylethylamine (DMPEA) and cocaine of norepinephrine-induced contraction of guinea-pig vas deferens. J Pharmacol Exp Ther (1974) 0.90

Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides. J Med Chem (2009) 0.90

Where there is no anesthetist--increasing capacity for emergency obstetric care in rural India: an evaluation of a pilot program to train general doctors. Int J Gynaecol Obstet (2009) 0.90

Relation between sleep duration and BMI varies by age and sex in youth age 8-19. Pediatr Obes (2011) 0.90

Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg (1998) 0.90

Increase in the heart rate variability with deep breathing in diabetic patients after 12-month exercise training. Tohoku J Exp Med (2010) 0.89

Trabectedin: an anticancer drug from the sea. Expert Opin Pharmacother (2009) 0.88

Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index. Ann Hum Genet (2008) 0.88

New phosphate binding agents: ferric compounds. J Am Soc Nephrol (1999) 0.87

Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer (1990) 0.87

Therapeutic angiogenesis: protein and gene therapy delivery strategies. J Cardiovasc Risk (1999) 0.86

Infection control in delivery care units, Gujarat state, India: a needs assessment. BMC Pregnancy Childbirth (2011) 0.85

A family physician's guide to monitoring methotrexate. Am Fam Physician (2000) 0.84

Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells. J Endocrinol (1992) 0.84

Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: part II. Bioorg Med Chem (2009) 0.84

Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience. Cancer Chemother Pharmacol (1993) 0.83

The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis. Arthritis Rheum (2004) 0.83

The benzodiazepine receptor inverse agonist RO 15-3505 reverses recent memory deficits in aged mice. Pharmacol Biochem Behav (1995) 0.82

Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein. J Endocrinol (1988) 0.82

Multiple cadherin superfamily members with unique expression profiles are produced in rat testis. Endocrinology (2000) 0.82

Effects of purine derivatives on calcitriol metabolism in rats. Am J Physiol (1991) 0.82

Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer (1992) 0.82

Moderate protection of renal function and reduction of fibrosis by colchicine in a model of anti-GBM disease in the rabbit. J Am Soc Nephrol (1990) 0.81

Mechanism of decreased intestinal calcitriol receptor concentration in renal failure. Am J Physiol (1993) 0.80

Investigation of the mechanism of decreased sensitivity of the rat seminal vesicle to norepinephrine by lithium. Pharmacology (1979) 0.80

Exogenous control of cardiac gene therapy: evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters. J Thorac Cardiovasc Surg (1999) 0.80

Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer (2001) 0.79

Attenuation over 24 hours of the efficacy of thrombolysis of pulmonary embolism among patients with cancer. Am Heart J (1997) 0.79

Postmenopausal bleeding. Med J Aust (1967) 0.79

Auscultated forced expiratory time as a clinical and epidemiologic test of airway obstruction. Chest (1991) 0.79

Mechanism of decreased calcitriol degradation in renal failure. Am J Physiol (1992) 0.78

Functionalized hydroxyethylamine based peptide nanostructures as potential inhibitors of falcipain-3, an essential proteases of Plasmodium falciparum. Bioorg Med Chem (2013) 0.78

Cytochrome P450 2C9 mediated metabolism in people with and without cancer. Int J Clin Pharmacol Ther (2008) 0.78

Regional variation in human retinal vessel oxygen saturation. Exp Eye Res (2013) 0.78

Protein synthesis and secretion by the human endometrium during the menstrual cycle and the effect of progesterone in vitro. J Reprod Fertil (1986) 0.78

Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: calcitriol receptor interaction with its target gene in renal failure. Curr Opin Nephrol Hypertens (1995) 0.78

Calcium and vitamin D metabolism in spontaneously hypertensive rats. Am J Physiol (1987) 0.77

Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp Hematol (1994) 0.77

Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation. Hematol Oncol Clin North Am (1995) 0.77

The biological action of calcitriol in renal failure. Kidney Int (1994) 0.77

SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia. Neuropharmacology (1993) 0.77

Monoclonal antibodies to human secretory "pregnancy-associated endometrial alpha 1-globulin," an insulin-like growth factor binding protein: characterization and use in radioimmunoassay, Western blots, and immunohistochemistry. Am J Reprod Immunol (1989) 0.77

Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J Clin Oncol (1994) 0.77

Uremic toxins and vitamin D metabolism. Kidney Int Suppl (1997) 0.76

Amniotic fluid concentrations of secreted pregnancy-associated endometrial alpha 1- and alpha 2-globulins (alpha 1- and alpha 2-PEG). Br J Obstet Gynaecol (1986) 0.76

Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors. Bioorg Med Chem Lett (2009) 0.76

The c-wave of the electroretinogram recorded under clinical conditions from rabbits. Doc Ophthalmol (1999) 0.75

The diagnostic value of the forced expiratory time. JAMA (1994) 0.75

Ifosfamide in sarcomas: is it a schedule-dependent drug? Cancer Invest (1996) 0.75

Treatment of the patient with lung metastases. Curr Probl Surg (1996) 0.75

Misconceptions with staging of soft tissue sarcoma. J Clin Oncol (2000) 0.75

Response to Chittari et al. Impact of acute hyperglycaemia on endothelial function and retinal vascular reactivity in patients with Type 2 diabetes. Diabet Med (2012) 0.75

The diagnostic challenge of Behçet's disease. Cleve Clin J Med (1993) 0.75

Dose equivalence of drugs for asthma. BMJ (1993) 0.75